Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Muscular Dystrophy, Duchenne

n(g),n(g')-dimethyl-l-arginine has been researched along with Muscular Dystrophy, Duchenne in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hörster, I1
Weigt-Usinger, K1
Carmann, C1
Chobanyan-Jürgens, K1
Köhler, C1
Schara, U1
Kayacelebi, AA1
Beckmann, B1
Tsikas, D1
Lücke, T1

Trials

1 trial available for n(g),n(g')-dimethyl-l-arginine and Muscular Dystrophy, Duchenne

ArticleYear
The L-arginine/NO pathway and homoarginine are altered in Duchenne muscular dystrophy and improved by glucocorticoids.
    Amino acids, 2015, Volume: 47, Issue:9

    Topics: Adolescent; Adult; Arginine; Child; Child, Preschool; Cross-Sectional Studies; Glucocorticoids; Homo

2015